These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23837977)

  • 1. [Expression of insulin-like growth factor 2 mRNA-binding protein 3 expression and analysis of prognosis in the patients with lung squamous cell carcinoma].
    Lin L; Zhang J; Wang Y; Zheng L; Lin Z; Cai Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):694-7. PubMed ID: 23837977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.
    Yan J; Wei Q; Jian W; Qiu B; Wen J; Liu J; Fu B; Zhou X; Zhao T
    Lung; 2016 Feb; 194(1):137-46. PubMed ID: 26608347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.
    Findeis-Hosey JJ; Xu H
    Biotech Histochem; 2012 Jan; 87(1):24-9. PubMed ID: 21838610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminin-5 and insulin-like growth factor-II mRNA binding protein-3 (IMP3) expression in preoperative biopsy specimens from oral cancer patients: Their role in neural spread risk and survival stratification.
    Tarsitano A; Asioli S; Morandi L; Monti V; Righi A; Morselli Labate AM; Nardi E; Foschini MP; Marchetti C
    J Craniomaxillofac Surg; 2016 Dec; 44(12):1896-1902. PubMed ID: 27863864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 Independently Predicts Worse Survival of Patients With Adenocarcinoma of the Ampulla of Vater.
    Kim HG; Park MS; Sung JY; Kim YW; Kim HS; Na K
    Anticancer Res; 2019 Sep; 39(9):4947-4955. PubMed ID: 31519600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
    Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
    J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinoma.
    Li HG; Han JJ; Huang ZQ; Wang L; Chen WL; Shen XM
    J Craniofac Surg; 2011 Nov; 22(6):2022-5. PubMed ID: 22067851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.
    Jeng YM; Chang CC; Hu FC; Chou HY; Kao HL; Wang TH; Hsu HC
    Hepatology; 2008 Oct; 48(4):1118-27. PubMed ID: 18802962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.
    Jiang Z; Chu PG; Woda BA; Rock KL; Liu Q; Hsieh CC; Li C; Chen W; Duan HO; McDougal S; Wu CL
    Lancet Oncol; 2006 Jul; 7(7):556-64. PubMed ID: 16814207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.
    Bi R; Shen X; Zhang W; Cheng Y; Feng Z; Cai X; Yang W
    Diagn Pathol; 2016 Feb; 11():17. PubMed ID: 26837693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of tissue and circulating levels of IMP3 in prostate cancer.
    Szarvas T; Tschirdewahn S; Niedworok C; Kramer G; Sevcenco S; Reis H; Shariat SF; Rübben H; vom Dorp F
    Int J Cancer; 2014 Oct; 135(7):1596-604. PubMed ID: 24615121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study.
    Wang L; Li HG; Xia ZS; Lü J; Peng TS
    Chin Med J (Engl); 2010 Dec; 123(24):3554-8. PubMed ID: 22166630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of downregulated ADARB1 in lung squamous cell carcinoma.
    Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z
    Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
    Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
    Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
    Chromecki TF; Cha EK; Pummer K; Scherr DS; Tewari AK; Sun M; Fajkovic H; Roehrborn CG; Ashfaq R; Karakiewicz PI; Shariat SF
    BJU Int; 2012 Jul; 110(1):63-8. PubMed ID: 22077633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.
    Kanzaki A; Kudo M; Ansai S; Peng WX; Ishino K; Yamamoto T; Wada R; Fujii T; Teduka K; Kawahara K; Kawamoto Y; Kitamura T; Kawana S; Saeki H; Naito Z
    Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
    Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
    Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.